**Chapter 10**

*Cheminformatics and Its Applications*

[71] Ramstrom O, Lehn JM. Drug discovery by dynamic combinatorial libraries. Nature Reviews. Drug

[72] Atterwill CK, Wing MG. In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development. Toxicology Letters.

[73] Boger E, Friden M. Physiologically

pharmacodynamic modeling accurately predicts the better bronchodilatory effect of inhaled versus oral salbutamol dosage forms. Journal of Aerosol Medicine and Pulmonary Drug

[74] Ekblom M, Hammarlund-Udenaes M,

White RE, Njoroge FG. Lead optimization

hepatitis C virus (HCV) protease inhibitor SCH 503034. Perspectives in Medicinal

Paalzow L. Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats. Journal of Pharmacology and Experimental Therapeutics. 1993;**266**:244-252

[75] Cheng KC, Korfmacher WA,

in discovery drug metabolism and pharmacokinetics/case study: The

[76] Balani SK, Miwa GT, Gan LS, Wu JT, Lee FW. Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection. Current Topics in Medicinal

Chemistry. 2005;**5**:1033-1038

[77] Braggio S, Montanari D, Rossi T, Ratti E. Drug efficiency: A new concept to guide lead optimization programs towards the selection of better clinical

Chemistry. 2007;**1**:1-9

Discovery. 2002;**1**:26-36

2002;**127**:143-151

based pharmacokinetic/

Delivery. 2019;**32**:1-12

[70] Kukanskis K, Elkind J, Melendez J, Murphy T, Miller G, Garner H. Detection of DNA hybridization using the TISPR-1 surface plasmon resonance biosensor. Analytical Biochemistry. 1999;**274**:7-17

candidates. Expert Opinion on Drug

[79] Sartori SB, Singewald N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacology & Therapeutics.

[80] Regan D, Garcia K, Thamm D. Clinical, pathological, and ethical considerations for the conduct of clinical trials in dogs with naturally occurring cancer: A comparative approach to accelerate translational drug development. ILAR Journal.

[81] Stephenson N, Shane E, Chase J, Rowland J, Ries D, Justice N, et al. Survey of machine learning techniques in drug discovery. Current Drug Metabolism. 2019;**20**:185-193

[78] Swann PG, Shapiro MA. Regulatory considerations for development of bioanalytical assays for biotechnology products. Bioanalysis. 2011;**3**:597-603

Discovery. 2010;**5**:609-618

2019;**204**:107402

2018;**59**:99-110

**146**
